Oncotarget Archives | Oncotarget

New Study: ATR Inhibition Reverses Chemo-Resistance in Subset of Cells

Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ)... read more

By Kathryn Atkins October 13, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more

By Oncotarget October 12, 2021

In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small... read more

By Kathryn Atkins September 30, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of... read more

By Oncotarget September 28, 2021

The mechanism(s) by which a nutrigenetic compound exerts its therapeutic effect on bronchial carcinoid... read more

By Kathryn Atkins September 21, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of... read more

By Oncotarget September 14, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more

By Oncotarget August 3, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of... read more

By Oncotarget June 22, 2021

Read short summaries of the latest oncology-focused research published in this week’s issue of... read more

By Oncotarget May 25, 2021

In this trending study, the association between IGF/CTP composite scores, overall survival, and progression-free... read more

By Kathryn Atkins May 7, 2021